Precigen, Inc. logo

Precigen, Inc.

NASDAQ:PGEN

Overview | Financials
Company Name Precigen, Inc.
Symbol PGEN
Currency USD
Price 0.937
Market Cap 269,645,561
Dividend Yield 0%
52-week-range 0.82 - 1.93
Industry Biotechnology
Sector Healthcare
CEO Dr. Helen Sabzevari MPH, Ph.D.
Website https://www.precigen.com

An error occurred while fetching data.

About Precigen, Inc.

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational

Related Stocks

AC Immune SA logo

AC Immune SA

ACIU

3.11 USD

ESSA Pharma Inc. logo

ESSA Pharma Inc.

EPIX

5.74 USD

Alpine Immune Sciences, Inc. logo

Alpine Immune Sciences, Inc.

ALPN

64.97 USD

Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc.

TNYA

1.91 USD

AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc.

ANTX

1.08 USD

Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

DYN

33.39 USD

Financials

Numbers are in millions USD

Numbers are in millions USD